Skip to main content
Loading

EveryONE Medicines

February 10, 2025
Orphan/Rare Diseases
EveryONE Medicines
EveryONE Medicines is committed to developing individualized anti-sense oligonucleotides targeting unique genetic variants causing severe neurodegenerative disease, even if unique to just one person.
Speakers
Kent Rogers, CEO - EveryONE Medicines
View all 2025 Program
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP